Anti Nausea Drug Zofran Linked to Serious Birth Defects

Zofran is used as an anti nausea drug, and was intended for providing relief to chemotherapy patients. The Food and Drug Administration (FDA) approved Zofran for treating the severe nausea and vomiting associated with chemotherapy treatments.

Zofran Was Never Intended For Pregnant Women

Recently, doctors have been prescribing Zofran for women in their first trimester of pregnancy, to help with the symptoms of morning sickness. The FDA notes that this is considered off-label use, and that they never approved the drug for treatment of morning sickness. Recent studies have shown a link between the use of Zofran and serious birth defects such as cleft palate and heart defects. More evidence has been found to indicate that Zofran is not safe for pregnant mothers. It is believed that GlaxoSmithKline misled patients by withholding information about the increased risk of birth defects.

Did You Take Zofran During Your Pregnancy? Talk To Us Today

Lawsuits have been filed as recently as June of 2015 by women who took Zofran during their pregnancy and delivered babies with birth defects such as heart defects such as ‘hole-in-the-heart’, ventricular septal defect, and atrial septal defect. In April of 2015 another suit was filed on behalf of the mother of a little girl with a cleft palate. This poor child has undergone over 10 surgeries to repair her birth defect.

Our pharmaceutical litigation attorneys fight for the rights of anyone who has suffered from the harmful side effects of any drug, including those who were prescribed Zofran during their pregnancy for nausea. If you were prescribed Zofran during your pregnancy and your child was born with birth defects, contact our law office for a Free Consultation about your legal rights. You may be eligible for compensation.

UPDATE (August 2015): The Olinde Firm and its co-counsel recently filed a lawsuit on behalf of a Massachusetts family against the manufacturer of Zofran, GlaxoSmithKline. The lawsuit seeks to hold GlaxoSmithKline responsible for marketing Zofran to doctors and pregnant women to treat morning sickness without studying the potential risks to the unborn child. After taking Zofran during her pregnancy, our client’s daughter was diagnosed with a birth defect (cleft lip) requiring multiple surgeries and ongoing treatment. Studies have linked Zofran use during the first trimester of pregnancy to an increased risk of birth defects, specifically cleft palate, cleft lip and heart defects.

Attorneys at The Olinde Firm continue to pursue claims against GlaxoSmithKline to hold the pharmaceutical giant responsible for its decision to put profits over the safety of its customers by marketing Zofran to expecting mothers without disclosing the increased risk of birth defects.